Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

121 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1.
Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E. Border WA, et al. Nature. 1990 Jul 26;346(6282):371-4. doi: 10.1038/346371a0. Nature. 1990. PMID: 2374609
Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells.
Huang Y, Noble NA, Zhang J, Xu C, Border WA. Huang Y, et al. Among authors: border wa. Kidney Int. 2007 Jul;72(1):45-52. doi: 10.1038/sj.ki.5002243. Epub 2007 Mar 28. Kidney Int. 2007. PMID: 17396111 Free article.
Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis.
Huang Y, Border WA, Lawrence DA, Noble NA. Huang Y, et al. Among authors: border wa. Kidney Int. 2006 Aug;70(3):515-22. doi: 10.1038/sj.ki.5000353. Epub 2006 Jun 21. Kidney Int. 2006. PMID: 16788698
Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
Peters H, Border WA, Noble NA. Peters H, et al. Among authors: border wa. Kidney Int. 2000 Apr;57(4):1493-501. doi: 10.1046/j.1523-1755.2000.00994.x. Kidney Int. 2000. PMID: 10760085
Angiotensin II in renal fibrosis: should TGF-beta rather than blood pressure be the therapeutic target?
Noble NA, Border WA. Noble NA, et al. Among authors: border wa. Semin Nephrol. 1997 Sep;17(5):455-66. Semin Nephrol. 1997. PMID: 9316214 Review.
Cytokines in kidney disease: the role of transforming growth factor-beta.
Border WA, Noble NA. Border WA, et al. Am J Kidney Dis. 1993 Jul;22(1):105-13. doi: 10.1016/s0272-6386(12)70175-0. Am J Kidney Dis. 1993. PMID: 8322771
Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-beta 1.
Nakamura T, Miller D, Ruoslahti E, Border WA. Nakamura T, et al. Among authors: border wa. Kidney Int. 1992 May;41(5):1213-21. doi: 10.1038/ki.1992.183. Kidney Int. 1992. PMID: 1614036
Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis.
Isaka Y, Akagi Y, Ando Y, Tsujie M, Sudo T, Ohno N, Border WA, Noble NA, Kaneda Y, Hori M, Imai E. Isaka Y, et al. Among authors: border wa. Kidney Int. 1999 Feb;55(2):465-75. doi: 10.1046/j.1523-1755.1999.00275.x. Kidney Int. 1999. PMID: 9987071
Increased levels of transforming growth factor-beta in HIV-associated nephropathy.
Yamamoto T, Noble NA, Miller DE, Gold LI, Hishida A, Nagase M, Cohen AH, Border WA. Yamamoto T, et al. Among authors: border wa. Kidney Int. 1999 Feb;55(2):579-92. doi: 10.1046/j.1523-1755.1999.00296.x. Kidney Int. 1999. PMID: 9987082
Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis.
Border WA, Noble NA. Border WA, et al. Hypertension. 1998 Jan;31(1 Pt 2):181-8. doi: 10.1161/01.hyp.31.1.181. Hypertension. 1998. PMID: 9453300 Review.
121 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback